In October 2025, Sharp announced plans to invest $100 million across its United States and European facilities to expand ...
Despite these pressures, loyalty to the field remains high. Indeed, more than 46% of respondents strongly disagree with leaving the bio/pharma industry entirely, a dip from the 59% who felt this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback